American Capital Sells Axygen for $400 Million

American Capital has sold Axygen BioScience Inc. to Corning Inc. for approximately $400 million. Axygen was acquired by American Capital in 2006, and is a Union City, Calif.–based distributor of life sciences plastic consumables, liquid handling products and bench-top laboratory equipment.

17 September 2009•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail